Combined nonmyeloablative total lymphoid irradiation and low-dose total body irradiation enhances donor chimerism and leads to islet allograft acceptance. [PDF]
Pathak S +16 more
europepmc +1 more source
Plasma Proteomic Analysis Reveals Complement System Changes in Irradiated Female BALB/c Mice during Mammary Carcinogenesis. [PDF]
Akbarzadeh T +8 more
europepmc +1 more source
ABSTRACT Background Type 1 diabetes mellitus (T1DM) is a chronic autoimmune disease marked by the destruction of pancreatic β‐cells, resulting in lifelong dependence on exogenous insulin. Despite advances in insulin delivery and glucose monitoring technologies, patients remain at risk for acute and long‐term complications, underscoring the need for ...
Tzu‐Min Lin +5 more
wiley +1 more source
Induction of autotetraploid and morphological, anatomical, and cytological studies of Trichosanthes cucumerina Linn. [PDF]
Liu CL, Huang HY, Xu FR.
europepmc +1 more source
Older female mice lacking triggering recepter expressed on myeloid cells-2 have worse post-stroke neurological function and enhanced pro-inflammatory responses [PDF]
Hsieh, C +4 more
core
Emerging Techniques in Minimally Invasive Surgery in Hematologic Malignancies
ABSTRACT Hematologic malignancies represent the most common cancers in children. While the mainstays of treatment are chemotherapy and potentially hematopoietic stem cell transplant, minimally invasive surgery (MIS) has a role in the diagnosis and management of complications related both to disease and therapy as well as common pediatric surgical ...
Alejandro Chara +3 more
wiley +1 more source
Interleukin-27 remodels the bone marrow niche to suppress B-cell development and leukaemia progression in mouse models. [PDF]
Zhu JM, Xia J, Chen KM, Bai XF, Duan CW.
europepmc +1 more source
The Brave New World of Embryonic Stem Cell Research: Utilitarian Consequentialism and Faulty Moral Reasoning [PDF]
Meyer, John R.
core +1 more source
ABSTRACT Patients with relapsed/refractory (R/R) diffuse large B‐cell lymphoma (DLBCL) who progress to the third‐line setting face a lack of standardized treatment, despite the presence of multiple available therapies. In this context, antibody–drug conjugates represent a relatively new class of anticancer agents; among them, loncastuximab tesirine is ...
Francesca Bonello +7 more
wiley +1 more source

